gabexate has been researched along with Nervous System Diseases in 2 studies
Gabexate: A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wakui, K | 1 |
| Takemae, T | 1 |
| Kobayashi, S | 1 |
| Inuzuka, T | 1 |
| Sato, S | 1 |
| Baba, H | 1 |
| Miyatake, T | 1 |
2 other studies available for gabexate and Nervous System Diseases
| Article | Year |
|---|---|
[Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Topics: Anticoagulants; Disseminated Intravascular Coagulation; Drug Evaluation; Female; Fibrin Fibrinogen D | 1990 |
Neutral protease in cerebrospinal fluid from patients with multiple sclerosis and other neurological diseases.
Topics: Amyotrophic Lateral Sclerosis; Endopeptidases; Esters; Follow-Up Studies; Gabexate; Guanidines; Huma | 1987 |